Roberto Pili Selected Research

Roberto Pili Research Topics

Disease

94	Neoplasms (Cancer) 01/2024 - 05/2002
52	Renal Cell Carcinoma (Grawitz Tumor) 01/2024 - 01/2004
51	Prostatic Neoplasms (Prostate Cancer) 09/2022 - 11/2004
14	Carcinoma (Carcinomatosis) 05/2023 - 06/2005
13	Neoplasm Metastasis (Metastasis) 12/2021 - 07/2007
11	Disease Progression 11/2020 - 09/2009
9	Fatigue 04/2023 - 08/2006
9	Hypoxia (Hypoxemia) 09/2020 - 09/2004
8	Urinary Bladder Neoplasms (Bladder Cancer) 11/2020 - 12/2013
7	Kidney Neoplasms (Kidney Cancer) 01/2024 - 07/2007
6	Hypertension (High Blood Pressure) 04/2023 - 08/2009
4	Melanoma (Melanoma, Malignant) 02/2015 - 01/2004
4	Colonic Neoplasms (Colon Cancer) 01/2014 - 07/2009
3	Hand-Foot Syndrome 04/2023 - 08/2009
3	Diarrhea 04/2023 - 08/2006
3	Exanthema (Rash) 05/2016 - 08/2006
2	Necrosis 05/2023 - 05/2020
2	Febrile Neutropenia 10/2018 - 06/2008
2	Cancer Pain 01/2018 - 01/2016
2	Anemia 07/2017 - 01/2016
2	Breast Neoplasms (Breast Cancer) 12/2013 - 05/2002
2	Carcinogenesis 07/2013 - 05/2002
2	Heart Failure 09/2011 - 08/2006
2	Adenocarcinoma 01/2011 - 08/2007

Drug/Important Bio-Agent (IBA)

23	Histone Deacetylase InhibitorsIBA 01/2020 - 09/2004
21	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2019 - 09/2003
19	Sunitinib (Sutent)FDA Link 04/2023 - 08/2009
15	Proteins (Proteins, Gene)FDA Link 01/2024 - 12/2002
13	Histone Deacetylases (Histone Deacetylase)IBA 01/2020 - 01/2006
12	AndrogensIBA 01/2020 - 08/2006
9	entinostat (MS 275)IBA 12/2017 - 05/2005
9	Tyrosine Kinase InhibitorsIBA 02/2015 - 09/2004
7	Biomarkers (Surrogate Marker)IBA 01/2023 - 10/2011
7	Immune Checkpoint InhibitorsIBA 12/2021 - 01/2017
7	Androgen Receptors (Androgen Receptor)IBA 11/2020 - 01/2008
7	Histones (Histone)IBA 09/2020 - 05/2002
7	Interleukin-2 (IL2)IBA 12/2017 - 08/2007
7	tasquinimodIBA 01/2016 - 12/2006
5	Hormones (Hormone)IBA 11/2020 - 09/2005
5	PanobinostatIBA 01/2020 - 01/2006
5	Cisplatin (Platino)FDA LinkGeneric 11/2019 - 02/2016
5	Bevacizumab (Avastin)FDA Link 03/2017 - 06/2004
5	Prostate-Specific Antigen (Semenogelase)IBA 01/2017 - 12/2009
5	Docetaxel (Taxotere)FDA Link 01/2014 - 08/2006
4	Phosphotransferases (Kinase)IBA 09/2022 - 09/2003
4	Peptides (Polypeptides)IBA 12/2021 - 01/2005
4	Mechanistic Target of Rapamycin Complex 1IBA 11/2020 - 01/2011
4	EnzymesIBA 01/2020 - 07/2009
4	Axitinib (AG 013736)IBA 01/2019 - 01/2015
4	LuciferasesIBA 09/2015 - 06/2005
4	Vascular Endothelial Growth Factor Receptors (VEGF Receptors)IBA 01/2015 - 09/2003
4	Angiogenesis InhibitorsIBA 04/2013 - 01/2006
3	Interferon-alpha (Interferon Alfa)IBA 04/2023 - 01/2004
3	Messenger RNA (mRNA)IBA 01/2023 - 12/2017
3	Sorafenib (BAY 43-9006)FDA Link 01/2023 - 05/2016
3	VaccinesIBA 12/2021 - 01/2012
3	Everolimus FDA Link 01/2020 - 01/2011
3	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 01/2020 - 12/2013
3	enzalutamideIBA 01/2020 - 04/2013
3	DNA (Deoxyribonucleic Acid)IBA 01/2019 - 08/2016
3	Dietary ProteinsIBA 12/2018 - 12/2013
3	SurvivinIBA 12/2018 - 09/2004
3	RNA (Ribonucleic Acid)IBA 12/2018 - 02/2015
3	afliberceptIBA 12/2017 - 07/2007
3	Antineoplastic Agents (Antineoplastics)IBA 02/2015 - 01/2011
3	vadimezanIBA 02/2012 - 04/2008
3	LAQ824IBA 01/2007 - 09/2004
3	Retinoic Acid Receptors (Retinoic Acid Receptor)IBA 06/2005 - 05/2002
2	Transcription Factors (Transcription Factor)IBA 01/2024 - 12/2002
2	Amino Acids FDA Link 09/2022 - 12/2018
2	Interleukin-6 (Interleukin 6)IBA 06/2020 - 12/2009
2	CytokinesIBA 06/2020 - 01/2017
2	abirateroneIBA 01/2020 - 04/2013
2	taxaneIBA 01/2020 - 12/2011
2	MTOR InhibitorsIBA 01/2020 - 02/2012
2	PolyaminesIBA 01/2020 - 11/2017
2	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 01/2019 - 03/2007
2	CrizotinibIBA 01/2019 - 01/2015
2	SeleniumIBA 04/2017 - 07/2012
2	Vorinostat FDA Link 03/2017 - 12/2009
2	Steroid 17-alpha-Hydroxylase (17 alpha Hydroxylase)IBA 03/2016 - 01/2012
2	ChromatinIBA 01/2016 - 01/2008
2	Drug CombinationsIBA 07/2015 - 06/2005
2	pazopanib FDA Link 02/2015 - 12/2013
2	cabazitaxel FDA Link 08/2013 - 04/2013
2	Prednisone (Sone)FDA LinkGeneric 08/2013 - 02/2011
2	sipuleucel-T (APC8015)FDA Link 04/2013 - 08/2011
2	Capsules (Microcapsules)IBA 01/2013 - 07/2007
2	Hypoxia-Inducible Factor 1IBA 07/2012 - 09/2006
2	2-MethoxyestradiolIBA 04/2012 - 12/2011
2	Acetic Acid (Vinegar)FDA LinkGeneric 02/2012 - 05/2010
2	4-hydroxy-2-nonenal (4-hydroxynonenal)IBA 10/2011 - 01/2011
2	Mitoxantrone (Novantrone)FDA LinkGeneric 02/2011 - 06/2004
2	TOR Serine-Threonine KinasesIBA 01/2011 - 06/2008

Therapy/Procedure

49	Therapeutics 01/2024 - 05/2002
18	Castration 11/2020 - 06/2008
11	Drug Therapy (Chemotherapy) 11/2019 - 06/2004
10	Immunotherapy 12/2021 - 09/2011
4	Nephrectomy 01/2016 - 09/2011
2	Neoadjuvant Therapy 02/2016 - 12/2013